scispace - formally typeset
C

Caterina Conte

Researcher at Vita-Salute San Raffaele University

Publications -  82
Citations -  4432

Caterina Conte is an academic researcher from Vita-Salute San Raffaele University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 25, co-authored 61 publications receiving 2581 citations. Previous affiliations of Caterina Conte include Sapienza University of Rome & The Catholic University of America.

Papers
More filters
Journal ArticleDOI

Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors.

TL;DR: It is recommended to assess psychopathology of COVID-19 survivors and to deepen research on inflammatory biomarkers, in order to diagnose and treat emergent psychiatric conditions.
Journal ArticleDOI

Resveratrol Supplementation Does Not Improve Metabolic Function in Nonobese Women with Normal Glucose Tolerance

TL;DR: It is demonstrated that resveratrol supplementation does not have beneficial metabolic effects in nonobese, postmenopausal women with normal glucose tolerance and consistent with the absence of in vivo metabolic effects.
Journal ArticleDOI

Probiotics in prevention and treatment of obesity: a critical view

TL;DR: Probiotics have physiologic functions that contribute to the health of gut microbiota, can affect food intake and appetite, body weight and composition and metabolic functions through gastrointestinal pathways and modulation of the gut bacterial community.
Journal ArticleDOI

Gastric bypass and banding equally improve insulin sensitivity and β cell function

TL;DR: It is concluded that marked weight loss itself is primarily responsible for the therapeutic effects of RYGB and LAGB on insulin sensitivity, β cell function, and oral glucose tolerance in nondiabetic obese adults.
Journal ArticleDOI

Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals

TL;DR: Adipose tissue from MAO individuals contains increased numbers of Th17 and Th22 cells, which produce cytokines that cause metabolic dysfunction in liver and muscle in vitro, which contributes to the pathogenesis of insulin resistance in obese people.